Lagumbay, Althea T.

HRN: 28-51-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/05/2026
02/11/2026
IV
21mg
OD
T/C Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: